Our primary areas of investigation are aimed at enhancing our understanding of cancer biology to discover and develop improved methods for cancer treatment. The goals are to establish new knowledge that can be directly translated into the design of clinical trials for current and future approaches.
Our major future objective is to significantly and positively contribute to translational research and clinical practice. Our recent particular areas of research are
- Drug discovery, design and development in different biological areas
(e.g. cancer, angiogenic, prokaryotes) - Tumor microenvironment
(e.g. vessel normalization, physiology, immunology) - Cancer glycobiology
(e.g. galectins) - Conventional treatments
(e.g. combinations, optimizations, new mechanisms)
We welcome any academic and industrial collaborations to advance and accelerate the research.